Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

被引：112

作者：

Kazemian, Pardis ^{[1
,2
]}

Yu, Si-Yue ^{[3
]}

Thomson, Sarah B. ^{[1
,2
]}

Birkenshaw, Alexandra ^{[3
]}

Leavitt, Blair R. ^{[1
,2
]}

Ross, Colin J. D. ^{[3
]}

机构：

[1] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada

[2] BC Childrens Hosp Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada

[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada

来源：

MOLECULAR PHARMACEUTICS | 2022年 / 19卷 / 06期

基金：

加拿大健康研究院;

关键词：

lipid nanoparticles; CRISPR; Cas9; genome editing; nanomedicine; gene therapy; IN-VIVO DELIVERY; MESSENGER-RNA; INTRACELLULAR DELIVERY; SYSTEMIC DELIVERY; CATIONIC LIPIDS; BLOOD PROTEINS; HOMING PEPTIDE; GENE-THERAPY; LIPOSOMES; EFFICIENT;

D O I：

10.1021/acs.molpharmaceut.1c00916

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Gene editing mediated by CRISPR/Cas9 systems is due to become a beneficial therapeutic option for treating genetic diseases and some cancers. However, there are challenges in delivering CRISPR components which necessitate sophisticated delivery systems for safe and effective genome editing. Lipid nanoparticles (LNPs) have become an attractive nonviral delivery platform for CRISPR-mediated genome editing due to their low immunogenicity and application flexibility. In this review, we provide a background of CRISPR-mediated gene therapy, as well as LNPs and their applicable characteristics for delivering CRISPR components. We then highlight the challenges of CRISPR delivery, which have driven the significant development of new, safe, and optimized LNP formulations in the past decade. Finally, we discuss considerations for using LNPs to deliver CRISPR and future perspectives on clinical translation of LNP-CRISPR gene editing

引用

页码：1669 / 1686

页数：18

共 50 条

[21] CRISPR/Cas9 genome editing in wheat
Dongjin Kim
Burcu Alptekin
Hikmet Budak
Functional & Integrative Genomics, 2018, 18 : 31 - 41
[22] CRISPR/Cas9 and Genome Editing in Drosophila
Bassett, Andrew R.
Liu, Ji-Long
JOURNAL OF GENETICS AND GENOMICS, 2014, 41 (01) : 7 - 19
[23] CRISPR/Cas9 and Genome Editing in Drosophila
Andrew R.Bassett
Ji-Long Liu
JournalofGeneticsandGenomics, 2014, 41 (01) : 7 - 19
[24] The CRISPR/Cas9 Genome Editing Revolution
Jiao, Renjie
Gao, Caixia
JOURNAL OF GENETICS AND GENOMICS, 2016, 43 (05) : 227 - 228
[25] CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity
Jose Franco-Tormo, Maria
Salas-Crisostomo, Mireille
Barbosa Rocha, Nuno
Budde, Henning
Machado, Sergio
Murillo-Rodriguez, Eric
JOURNAL OF MOLECULAR NEUROSCIENCE, 2018, 65 (01) : 10 - 16
[26] CRISPR/Cas9 genome editing in wheat
Kim, Dongjin
Alptekin, Burcu
Budak, Hikmet
FUNCTIONAL & INTEGRATIVE GENOMICS, 2018, 18 (01) : 31 - 41
[27] CRISPR/Cas9 in Genome Editing and Beyond
Wang, Haifeng
La Russa, Marie
Qi, Lei S.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85, 2016, 85 : 227 - 264
[28] CRISPR/Cas9 genome editing in crops
Smedley, Mark
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT, 2018, 54 : S104 - S104
[29] Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
Huan Deng
Wei Huang
Zhiping Zhang
Nano Research, 2019, 12 : 2437 - 2450
[30] Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
Deng, Huan
Huang, Wei
Zhang, Zhiping
NANO RESEARCH, 2019, 12 (10) : 2437 - 2450

← 1 2 3 4 5 →